We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
A cohort study of comorbidity in patients with granulomatosis with polyangiitis.
Rheumatology 2018 Februrary 2
Objectives: To evaluate the associations between granulomatosis with polyangiitis (GPA) and a wide range of comorbidities in patients with GPA compared with population-based non-vasculitis patients.
Methods: Using the UK-based Clinical Practice Research Datalink we identified 570 incident patients with GPA in 1990-2014, and for each case, we selected up to 10 random non-vasculitis patients matched for age, sex, practice and years of history before the date of first GPA diagnosis. We compared the distribution of 13 pre-existing comorbidities and estimated the risk of each incident comorbidity after the cohort entry between GPA and non-vasculitis patients.
Results: Patients with GPA were more likely to have a history of hypothyroidism at their initial diagnosis compared with non-vasculitis patients. Patients with GPA had increased risk of incident venous thromboembolism any time during follow-up compared with non-vasculitis patients, particularly during the first 3 years of follow-up: hazard ratio (HR) of 5.24 (95% CI: 2.83, 9.71). Risks were also increased for hypertension (HR = 2.45, 95% CI: 1.84, 3.26), type 2 diabetes (HR = 2.13, 95% CI: 1.36, 3.32), dyslipidaemia (HR = 1.98, 95% CI: 1.29, 3.04) and depression (HR = 1.77, 95% CI: 1.10, 2.86) among GPA patients during the first 3 years of follow-up, but not after 3 years post-diagnosis.
Conclusion: Patients with GPA had a higher prevalence of hypothyroidism before the initial diagnosis, a strong risk of developing venous thromboembolism during follow-up and increased risks of hypertension, dyslipidaemia, type 2 diabetes and depression in the first few years after diagnosis, compared with non-vasculitis population.
Methods: Using the UK-based Clinical Practice Research Datalink we identified 570 incident patients with GPA in 1990-2014, and for each case, we selected up to 10 random non-vasculitis patients matched for age, sex, practice and years of history before the date of first GPA diagnosis. We compared the distribution of 13 pre-existing comorbidities and estimated the risk of each incident comorbidity after the cohort entry between GPA and non-vasculitis patients.
Results: Patients with GPA were more likely to have a history of hypothyroidism at their initial diagnosis compared with non-vasculitis patients. Patients with GPA had increased risk of incident venous thromboembolism any time during follow-up compared with non-vasculitis patients, particularly during the first 3 years of follow-up: hazard ratio (HR) of 5.24 (95% CI: 2.83, 9.71). Risks were also increased for hypertension (HR = 2.45, 95% CI: 1.84, 3.26), type 2 diabetes (HR = 2.13, 95% CI: 1.36, 3.32), dyslipidaemia (HR = 1.98, 95% CI: 1.29, 3.04) and depression (HR = 1.77, 95% CI: 1.10, 2.86) among GPA patients during the first 3 years of follow-up, but not after 3 years post-diagnosis.
Conclusion: Patients with GPA had a higher prevalence of hypothyroidism before the initial diagnosis, a strong risk of developing venous thromboembolism during follow-up and increased risks of hypertension, dyslipidaemia, type 2 diabetes and depression in the first few years after diagnosis, compared with non-vasculitis population.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app